News

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
Bill Gates has warned that AI will replace many jobs, but says coding will stay a fully human profession, even hundreds of ...
Google on Thursday announced the second cohort to take part in its AI Academy: American Infrastructure, which seeks to ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
Alphabet’s AI-powered drug discovery company, Isomorphic Labs, is preparing to take its first major leap into the real world.
Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...
Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...
Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence.
DeepMind's new AI system gives robots an inner voice, enabling zero-shot learning and efficient task mastery without prior training.
Explore Microsoft's AI Diagnostic Orchestrator, achieving 85.5% diagnostic accuracy, revolutionizing healthcare diagnostics.